SRx Health Solutions Appoints Joshua Epstein to Board of Directors and Compensation Committee

Rhea-AI Summary

SRx Health Solutions (NYSE American: SRXH) has announced the appointment of Joshua Epstein to its Board of Directors and Compensation Committee. The announcement represents a straightforward addition to the company's governance structure.

The press release primarily consists of standard forward-looking statements and contact information, with no additional details provided about Epstein's background, qualifications, or specific contributions expected in his new role.

News Market Reaction – SRXH

+0.95%

20 alerts

+0.95% Session close to close

+30.0% Peak in 29 hr 4 min

$12.95M Market Cap

1.5x Rel. Volume

In the Oct 1 session, SRXH gained 0.95%, reflecting a mild positive market reaction. Argus tracked a peak move of +30.0% during that session. Our momentum scanner triggered 20 alerts that day, indicating elevated trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

TAMPA, Fla., Oct. 01, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”) today announced the appointment of Joshua Epstein to the Board of Directors and Compensation Committee.

Forward Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words “believe,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “could,” “target,” “potential,” “is likely,” “will,” “expect” and similar expressions, as they relate to us, are intended to identify forward-looking statements. The Company has based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. Some or all of the results anticipated by these forward-looking statements may not be achieved. Further information on the Company’s risk factors is contained in our filings with the SEC. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.

Company Contact:
SRx Health Solutions, Inc.
Kent Cunningham, Chief Executive Officer

Investor Contact:
KCSA Strategic Communications
Valter Pinto, Managing Director
T: 212-896-1254
Valter@KCSA.com

FAQ

Who is the new board member appointed to SRx Health Solutions (SRXH)?

Joshua Epstein has been appointed to SRx Health Solutions' Board of Directors and Compensation Committee.

What positions will Joshua Epstein hold at SRXH?

Joshua Epstein will serve on both the Board of Directors and the Compensation Committee at SRx Health Solutions.

Who is the current CEO of SRx Health Solutions (SRXH)?

Kent Cunningham is the Chief Executive Officer of SRx Health Solutions.

How can investors contact SRx Health Solutions (SRXH)?

Investors can contact SRx Health Solutions through their investor relations representative, Valter Pinto at KCSA Strategic Communications, at 212-896-1254 or Valter@KCSA.com.